The multifaceted allosteric regulation of Aurora kinase A
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The protein kinase Aurora A (AurA) is essential for the formation of bipolar mitotic spindles in all eukaryotic organisms. During spindle assembly, AurA is activated through two different pathways operating at centrosomes and on spindle microtubules. Recent studies have revealed that these pathways operate quite differently at the molecular level, activating AurA through multifaceted changes to the structure and dynamics of the kinase domain. These advances provide an intimate atomic-level view of the finely tuned regulatory control operating in protein kinases, revealing mechanisms of allosteric cooperativity that provide graded levels of regulatory control, and a previously unanticipated mechanism for kinase activation by phosphorylation on the activation loop. Here, I review these advances in our understanding of AurA function, and discuss their implications for the use of allosteric small molecule inhibitors to address recently discovered roles of AurA in neuroblastoma, prostate cancer and melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This feature is common in activated kinases18, but in Cdk2 the β-sheet is out of register, and instead stabilizes an inactive conformation in which the T160 residue is presented for dephosphorylation.”
From Allostery governs Cdk2 activation and differential recognition of CDK inhibitors (2021) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294
García-Martínez, J. M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20081668 · Cited by 907
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
Biondi, R. M., Kieloch, A., Currie, R. A., Deak, M., & Alessi, D. R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.16.4380 · Cited by 377
Frödin, M., Antal, T. L., Dümmler, B. A., Jensen, C. J., Deak, M., Gammeltoft, S., & Biondi, R. M. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf551 · Cited by 275
Research works printed but not linked: 97
- Glover, 1995, Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles, Cell, 81, 95, 10.1016/0092-8674(95)90374-7 · DOI · Paper page
- Chan, 1993, Isolation and characterization of chromosome-gain and increase-in-ploidy mutants in yeast, Genetics, 135, 677, 10.1093/genetics/135.3.677 · DOI · Paper page
- Roghi, 1998, The Xenopus protein kinase pEg2 associates with the centrosome in a cell cycle-dependent manner, binds to the spindle microtubules and is involved in bipolar mitotic spindle assembly, J. Cell Sci., 111, 557, 10.1242/jcs.111.5.557 · DOI · Paper page
- Schumacher, 1998, AIR-2: an Aurora/Ipl1-related protein kinase associated with chromosomes and midbody microtubules is required for polar body extrusion and cytokinesis in Caenorhabditis elegans embryos, J. Cell Biol., 143, 1635, 10.1083/jcb.143.6.1635 · DOI · Paper page
- Bischoff, 1998, A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers, EMBO J., 17, 3052, 10.1093/emboj/17.11.3052 · DOI · Paper page
- Zhou, 1998, Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation, Nat. Genet., 20, 189, 10.1038/2496 · DOI · Paper page
- Kimura, 1999, Cell cycle-dependent expression and centrosome localization of a third human aurora/Ipl1-related protein kinase, AIK3, J. Biol. Chem., 274, 7334, 10.1074/jbc.274.11.7334 · DOI · Paper page
- Carmena, 2003, The cellular geography of aurora kinases, Nat. Rev. Mol. Cell Biol., 4, 842, 10.1038/nrm1245 · DOI · Paper page
- Hannak, 2001, Aurora-A kinase is required for centrosome maturation in Caenorhabditis elegans, J. Cell Biol., 155, 1109, 10.1083/jcb.200108051 · DOI · Paper page
- Seki, 2008, Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry, Science, 320, 1655, 10.1126/science.1157425 · DOI · Paper page
- Macůrek, 2008, Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery, Nature, 455, 119, 10.1038/nature07185 · DOI · Paper page
- Kufer, 2002, Human TPX2 is required for targeting Aurora-A kinase to the spindle, J. Cell Biol., 158, 617, 10.1083/jcb.200204155 · DOI · Paper page
- Cheung, 2009, Aurora kinase inhibitors in preclinical and clinical testing, Expert. Opin. Investig. Drugs, 18, 379, 10.1517/13543780902806392 · DOI
- Boss, 2009, Clinical experience with aurora kinase inhibitors: a review, Oncologist, 14, 780, 10.1634/theoncologist.2009-0019 · DOI
- Bavetsias, 2015, Aurora kinase inhibitors: current status and outlook, Front. Oncol., 5, 278, 10.3389/fonc.2015.00278 · DOI · Paper page
- Paez, 2004, EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy, Science, 304, 1497, 10.1126/science.1099314 · DOI · Paper page
- Hammond, 2013, Melanoma-associated mutations in protein phosphatase 6 cause chromosome instability and DNA damage owing to dysregulated Aurora-A, J. Cell Sci, 126, 3429, 10.1242/jcs.128397 · DOI
- Otto, 2009, Stabilization of N-Myc is a critical function of Aurora A in human neuroblastoma, Cancer Cell, 15, 67, 10.1016/j.ccr.2008.12.005 · DOI · Paper page
- Lee, 2016, N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells, Cancer Cell, 29, 536, 10.1016/j.ccell.2016.03.001 · DOI · Paper page
- Honda, 2000, Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway, Oncogene, 19, 2812, 10.1038/sj.onc.1203609 · DOI
- Littlepage, 2002, Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit, Genes Dev., 16, 2274, 10.1101/gad.1007302 · DOI · Paper page
- Zhang, 2007, Identification of the auto-inhibitory domains of Aurora-A kinase, Biochem. Biophys. Res. Commun., 357, 347, 10.1016/j.bbrc.2007.03.129 · doi:10.1016/j.bbrc.2007.03.129
- Manning, 2002, The protein kinase complement of the human genome, Science, 298, 1912, 10.1126/science.1075762 · DOI · Paper page
- Huse, 2002, The conformational plasticity of protein kinases, Cell, 109, 275, 10.1016/S0092-8674(02)00741-9 · DOI · Paper page
- Nolen, 2004, Regulation of protein kinases; controlling activity through activation segment conformation, Mol. Cell, 15, 661, 10.1016/j.molcel.2004.08.024 · DOI · Paper page
- Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
- Bayliss, 2003, Structural basis of Aurora-A activation by TPX2 at the mitotic spindle, Mol. Cell, 12, 851, 10.1016/S1097-2765(03)00392-7 · DOI · Paper page
- Alessi, 1996, Mechanism of activation of protein kinase B by insulin and IGF-1, EMBO J., 15, 6541, 10.1002/j.1460-2075.1996.tb01045.x · DOI · Paper page
- Sarbassov, 2005, Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex, Science, 307, 1098, 10.1126/science.1106148 · DOI · Paper page
- Collins, 2003, In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation, EMBO J., 22, 4202, 10.1093/emboj/cdg407 · DOI · Paper page
- Cyphers, 2017, A water-mediated allosteric network governs activation of Aurora kinase A, Nat. Chem. Biol., 13, 402, 10.1038/nchembio.2296 · DOI · Paper page
- Gadde, 2004, Mechanisms and molecules of the mitotic spindle, Curr. Biol., 14, R797, 10.1016/j.cub.2004.09.021 · DOI · Paper page
- Heald, 1996, Self-organization of microtubules into bipolar spindles around artificial chromosomes in Xenopus egg extracts, Nature, 382, 420, 10.1038/382420a0 · DOI · Paper page
- Heald, 1997, Spindle assembly in Xenopus egg extracts: respective roles of centrosomes and microtubule self-organization, J. Cell Biol., 138, 615, 10.1083/jcb.138.3.615 · DOI · Paper page
- Sawin, 1991, Mitotic spindle assembly by two different pathways in vitro, J. Cell Biol., 112, 925, 10.1083/jcb.112.5.925 · DOI · Paper page
- Gruss, 2001, Ran induces spindle assembly by reversing the inhibitory effect of importin α on TPX2 activity, Cell, 104, 83, 10.1016/S0092-8674(01)00193-3 · DOI · Paper page
- Tsai, 2003, A Ran signalling pathway mediated by the mitotic kinase Aurora A in spindle assembly, Nat. Cell Biol., 5, 242, 10.1038/ncb936 · DOI · Paper page
- Pinyol, 2013, The role of NEDD1 phosphorylation by Aurora A in chromosomal microtubule nucleation and spindle function, Curr. Biol., 23, 143, 10.1016/j.cub.2012.11.046 · DOI
- Wong, 2008, Aurora A regulates the activity of HURP by controlling the accessibility of its microtubule-binding domain, Mol. Biol. Cell, 19, 2083, 10.1091/mbc.e07-10-1088 · DOI · Paper page
- Ma, 2010, Poleward transport of TPX2 in the mammalian mitotic spindle requires dynein, Eg5, and microtubule flux, Mol. Biol. Cell, 21, 979, 10.1091/mbc.e09-07-0601 · DOI
- Joukov, 2010, Centrosomal protein of 192 kDa (Cep192) promotes centrosome-driven spindle assembly by engaging in organelle-specific Aurora A activation, Proc. Natl Acad. Sci. U.S.A., 107, 21022, 10.1073/pnas.1014664107 · DOI
- Hirota, 2003, Aurora-A and an interacting activator, the LIM protein Ajuba, are required for mitotic commitment in human cells, Cell, 114, 585, 10.1016/S0092-8674(03)00642-1 · DOI · Paper page
- Kinoshita, 2005, Aurora A phosphorylation of TACC3/maskin is required for centrosome-dependent microtubule assembly in mitosis, J. Cell Biol., 170, 1047, 10.1083/jcb.200503023 · DOI · Paper page
- Peset, 2005, Function and regulation of Maskin, a TACC family protein, in microtubule growth during mitosis, J. Cell Biol., 170, 1057, 10.1083/jcb.200504037 · DOI · Paper page
- Joukov, 2014, The Cep192-organized aurora A-Plk1 cascade is essential for centrosome cycle and bipolar spindle assembly, Mol. Cell, 55, 578, 10.1016/j.molcel.2014.06.016 · DOI
- Dodson, 2013, A kinetic test characterizes kinase intramolecular and intermolecular autophosphorylation mechanisms, Sci. Signal., 6, ra54, 10.1126/scisignal.2003910 · DOI
- Zorba, 2014, Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2, eLife, 3, e02667, 10.7554/eLife.02667 · DOI
- Gomez-Ferreria, 2007, Human Cep192 is required for mitotic centrosome and spindle assembly, Curr. Biol., 17, 1960, 10.1016/j.cub.2007.10.019 · DOI · Paper page
- Kemp, 2004, Centrosome maturation and duplication in C. elegans require the coiled-coil protein SPD-2, Dev. Cell, 6, 511, 10.1016/S1534-5807(04)00066-8 · DOI · Paper page
- Eyers, 2003, A novel mechanism for activation of the protein kinase Aurora A, Curr. Biol, 13, 691, 10.1016/S0960-9822(03)00166-0 · DOI · Paper page
- Toya, 2011, A kinase-independent role for Aurora A in the assembly of mitotic spindle microtubules in Caenorhabditis elegans embryos, Nat. Cell Biol., 13, 708, 10.1038/ncb2242 · DOI
- Dutertre, 2004, Phosphorylation of CDC25B by Aurora-A at the centrosome contributes to the G2-M transition, J. Cell Sci, 117, 2523, 10.1242/jcs.01108 · DOI · Paper page
- Zeng, 2010, Protein phosphatase 6 regulates mitotic spindle formation by controlling the T-loop phosphorylation state of Aurora A bound to its activator TPX2, J. Cell Biol., 191, 1315, 10.1083/jcb.201008106 · DOI · Paper page
- Dodson, 2012, Activation of Aurora-A kinase by protein partner binding and phosphorylation are independent and synergistic, J. Biol. Chem., 287, 1150, 10.1074/jbc.M111.312090 · DOI
- Kornev, 2006, Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism, Proc. Natl Acad. Sci. U.S.A., 103, 17783, 10.1073/pnas.0607656103 · DOI · Paper page
- Kornev, 2008, A helix scaffold for the assembly of active protein kinases, Proc. Natl Acad. Sci. U.S.A., 105, 14377, 10.1073/pnas.0807988105 · DOI · Paper page
- Gutmann, 2015, The crystal structure of cancer Osaka thyroid kinase reveals an unexpected kinase domain fold, J. Biol. Chem., 290, 15210, 10.1074/jbc.M115.648097 · DOI
- Kothe, 2007, Structure of the catalytic domain of human polo-like kinase 1, Biochemistry, 46, 5960, 10.1021/bi602474j · doi:10.1021/bi602474j
- Carry, 2015, SAR156497, an exquisitely selective inhibitor of aurora kinases, J. Med. Chem., 58, 362, 10.1021/jm501326k · DOI
- Matheson, 2016, Targeting WEE1 kinase in cancer, Trends Pharmacol. Sci., 37, 872, 10.1016/j.tips.2016.06.006 · DOI · Paper page
- Hubbard, 1994, Crystal structure of the tyrosine kinase domain of the human insulin receptor, Nature, 372, 746, 10.1038/372746a0 · DOI · Paper page
- Nagar, 2003, Structural basis for the autoinhibition of c-Abl tyrosine kinase, Cell, 112, 859, 10.1016/S0092-8674(03)00194-6 · DOI · Paper page
- Mol, 2004, Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase, J. Biol. Chem., 279, 31655, 10.1074/jbc.M403319200 · DOI · Paper page
- Shan, 2009, A conserved protonation-dependent switch controls drug binding in the Abl kinase, Proc. Natl Acad. Sci. U.S.A., 106, 139, 10.1073/pnas.0811223106 · DOI · Paper page
- Agafonov, 2014, Energetic dissection of Gleevec's selectivity toward human tyrosine kinases, Nat. Struct. Mol. Biol., 21, 848, 10.1038/nsmb.2891 · DOI · Paper page
- Zhao, 2014, Exploration of type II binding mode: A privileged approach for kinase inhibitor focused drug discovery?, ACS Chem. Biol., 9, 1230, 10.1021/cb500129t · DOI · Paper page
- Martin, 2012, A novel mechanism by which small molecule inhibitors induce the DFG flip in Aurora A, ACS Chem. Biol., 7, 698, 10.1021/cb200508b · doi:10.1021/cb200508b
- Dodson, 2010, Crystal structure of an Aurora-A mutant that mimics Aurora-B bound to MLN8054: insights into selectivity and drug design, Biochem. J., 427, 19, 10.1042/BJ20091530 · DOI · Paper page
- de Groot, 2015, A cell biologist's field guide to aurora kinase inhibitors, Front. Oncol., 5, 285, 10.3389/fonc.2015.00285 · DOI · Paper page
- Fancelli, 2006, 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile, J. Med. Chem., 49, 7247, 10.1021/jm060897w · DOI · Paper page
- Nowakowski, 2002, Structures of the cancer-related Aurora-A, FAK, and EphA2 protein kinases from nanovolume crystallography, Structure, 10, 1659, 10.1016/S0969-2126(02)00907-3 · DOI · Paper page
- Lawrence, 2012, Development of o-chlorophenyl substituted pyrimidines as exceptionally potent aurora kinase inhibitors, J. Med. Chem., 55, 7392, 10.1021/jm300334d · DOI
- Coumar, 2009, Structure-based drug design of novel Aurora kinase A inhibitors: structural basis for potency and specificity, J. Med. Chem., 52, 1050, 10.1021/jm801270e · doi:10.1021/jm801270e
- Coumar, 2010, Identification, SAR studies, and X-ray co-crystallographic analysis of a novel furanopyrimidine aurora kinase A inhibitor, ChemMedChem, 5, 255, 10.1002/cmdc.200900339 · doi:10.1002/cmdc.200900339
- Wu, 2013, Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules, Proc. Natl Acad. Sci. U.S.A., 110, E1779, 10.1073/pnas.1220523110 · DOI
- Burgess, 2016, Allosteric inhibition of Aurora-A kinase by a synthetic vNAR domain, Open Biol., 6, 160089, 10.1098/rsob.160089 · DOI · Paper page
- Levinson, 2006, A Src-like inactive conformation in the abl tyrosine kinase domain, PLoS Biol., 4, e144, 10.1371/journal.pbio.0040144 · DOI · Paper page
- McClendon, 2014, Dynamic architecture of a protein kinase, Proc. Natl Acad. Sci. U.S.A., 111, E4623, 10.1073/pnas.1418402111 · DOI · Paper page
- Johnson, 1996, Active and inactive protein kinases: structural basis for regulation, Cell, 85, 149, 10.1016/S0092-8674(00)81092-2 · DOI · Paper page
- Gilburt, 2017, Dynamic equilibrium of the Aurora A kinase activation loop revealed by single-molecule spectroscopy, Angew. Chem. Int. Ed. Engl., 56, 11409, 10.1002/anie.201704654 · DOI
- Ruff, 2018, A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation, eLife, 7, e32766, 10.7554/eLife.32766 · DOI
- Smith, 2004, The structure of MSK1 reveals a novel autoinhibitory conformation for a dual kinase protein, Structure, 12, 1067, 10.1016/j.str.2004.02.040 · DOI
- De Bondt, 1993, Crystal structure of cyclin-dependent kinase 2, Nature, 363, 595, 10.1038/363595a0 · DOI · Paper page
- Xu, 1997, Three-dimensional structure of the tyrosine kinase c-Src, Nature, 385, 595, 10.1038/385595a0 · DOI · Paper page
- Burgess, 2018, Mitotic spindle association of TACC3 requires Aurora-A-dependent stabilization of a cryptic α-helix, EMBO J., 37, e97902, 10.15252/embj.201797902 · DOI
- Levinson, 2008, Structural basis for the recognition of c-Src by its inactivator Csk, Cell, 134, 124, 10.1016/j.cell.2008.05.051 · DOI · Paper page
- Novotny, 2005, A survey of left-handed helices in protein structures, J. Mol. Biol., 347, 231, 10.1016/j.jmb.2005.01.037 · DOI
- Eisenberg, 1986, Solvation energy in protein folding and binding, Nature, 319, 199, 10.1038/319199a0 · DOI · Paper page
- Nozaki, 1971, The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions. Establishment of a hydrophobicity scale, J. Biol. Chem., 246, 2211, 10.1016/S0021-9258(19)77210-X · DOI · Paper page
- Janeček, 2016, Allosteric modulation of AURKA kinase activity by a small-molecule inhibitor of its protein-protein interaction with TPX2, Sci. Rep., 6, 28528, 10.1038/srep28528 · DOI
- McIntyre, 2017, Characterization of three druggable hot-spots in the Aurora-A/TPX2 interaction using biochemical, biophysical, and fragment-based approaches, ACS Chem. Biol., 12, 2906, 10.1021/acschembio.7b00537 · DOI
- Gold, 2014, PP6C hotspot mutations in melanoma display sensitivity to Aurora kinase inhibition, Mol. Cancer Res., 12, 433, 10.1158/1541-7786.MCR-13-0422 · DOI
- Brodeur, 1984, Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage, Science, 224, 1121, 10.1126/science.6719137 · DOI · Paper page
- Brockmann, 2013, Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma, Cancer Cell, 24, 75, 10.1016/j.ccr.2013.05.005 · DOI · Paper page
- Gustafson, 2014, Drugging MYCN through an allosteric transition in Aurora kinase A, Cancer Cell, 26, 414, 10.1016/j.ccr.2014.07.015 · DOI · Paper page
- Richards, 2016, Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors, Proc. Natl Acad. Sci. U.S.A., 113, 13726, 10.1073/pnas.1610626113 · DOI · Paper page
- DuBois, 2016, Phase I study of the Aurora A kinase inhibitor alisertib in combination with irinotecan and temozolomide for patients With relapsed or refractory neuroblastoma: A NANT (new approaches to neuroblastoma therapy) trial, J. Clin. Oncol., 34, 1368, 10.1200/JCO.2015.65.4889 · DOI
Cited by
Verkhivker, G. M., Agajanian, S., Hu, G., & Tao, P. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00136 · Cited by 76
Allostery governs Cdk2 activation and differential recognition of CDK inhibitors
Majumdar, A., Burban, D. J., Muretta, J. M., Thompson, A. R., Engel, T. A., Rasmussen, D. M., Subrahmanian, M. V., Veglia, G., Thomas, D. D., & Levinson, N. M. (2021) · Nature Chemical Biology · doi:10.1038/s41589-020-00725-y · Cited by 65
Self-citation
Metadata
- Authors
- Levinson, N. M.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 2018-06-26
- Volume
- 475
- Issue
- 12
- Pages
- 2025-2042
- ISSN
- 0264-6021
- 1470-8728
- Cited by
- 65
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.